Rockefeller University
Sanofi’s Tzield gets expanded FDA approval for early-stage type 1 diabetes
The treatment can be used to delay the onset of clinical type 1 diabetes
Diabeloop’s DBLG2 receives FDA and CE clearance for automated insulin delivery without meal input
While a lack of meal announcements can lead to lower glycaemic control, it reduces the mental burden for those with type 1 diabetes
UK drug repurposing study identifies several potential dementia treatments
An estimated 982,000 people in the UK are currently living with the neurodegenerative disease
KCL research could speed up discovery of new antibiotics in fight against AMR
According to WHO, AMR is designated as one of the top ten global public health threats facing humanity
Study finds siblings with unique genetic defects could help progress type 1 diabetes drug search
The chronic, life-long disease affected around 8.4 million people worldwide in 2021
NHS rolls out artificial pancreas for adults and children with type 1 diabetes in England
Type 1 diabetes accounts for approximately 10% of all diabetes cases in the UK
Single genetic test could replace current standard for diagnosing rare developmental disorders
The single genetic test could potentially replace the current standard and reduce costs for the NHS
King’s College London and 11 London collaborate on health psychology
We’re delighted to announce that we are working in partnership with the Health Psychology department at King's College London. Professor Rona Moss-Morris is working with the agency on a shared...
New genetic risk tool could predict multiple sclerosis in young adults much earlier
Approximately 2.8 million people worldwide are affected by the disabling neurological disease
Incisionless device to transform diabetes, liver disease and severe obesity treatment
ForePass replicates common invasive metabolic surgeries without making any incisions
Study programme to investigate blocking brain inflammation in Parkinson’s patients
If successful, the findings could lead to new medicines to treat the neurological disease
Study suggests health and lifestyle factors could be linked to young-onset dementia
There are around 370,000 new cases of young-onset dementia globally every year